Impact Factor
7.883
Call For Paper
Volume 12 Issue 07
July 2026
Download Paper Format
Copyright Form
Author(s)
Mr. Prathamesh N. Pawar Prof. S. R. Ghodke Dr. H. V. Kambale Sagar A.Daitkar
Abstract
This Review Article Comprehensively Examines The Bioanalytical Method Development Of Dapagliflozin From Human Plasma Using LC-MS/MS (liquid Chromatography-tandem Mass Spectrometry). Dapagliflozin, A Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor, Holds
Keywords
Dapagliflozin
LC-MS/MS
Bioanalytical Method Development
Human Plasma
Type 2 Diabetes Mellitus
Pharmacokinetics
Paper ID
IJSARTV10I693219
Publication Date
June 8, 2024
Research Area
Pharmaceutics